Hereditary transthyretin amyloidosis polyneuropathy in patients with carpal tunnel syndrome in Russia - LOCUS

Study identifier:D8451R00001

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

A multicenter observational retrospective-prospective study of prevalence, clinical characteristics of hereditary transthyretin amyloidosis polyneuropathy in Russian patients undergoing surgery for CTS in real clinical practice

Medical condition

hereditary transthyretin amyloidosis, CTS, PN

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

880

Study type

Observational

Age

n/a - n/a

Date

Study Start Date: 29 Dec 2023
Estimated Primary Completion Date: 31 Dec 2024
Estimated Study Completion Date: 31 Dec 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Mar 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria